Oral CXA-10 in Pulmonary Arterial Hypertension

NCT04125745 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

INDIV

Sponsor class

Stopped negative study outcome from Complexa's multicenter clinical trial; no safety concerns

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: CXA-10

Sponsor

Gladwin, Mark, MD

Collaborators

[object Object]
[object Object]